Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Berek

Showing results (31-40 of 172) with videos related to

Pageof 18
Sort By:
Hematology/Oncology Clinics of North America|August 1, 1992
Biologic and immunologic therapy of ovarian cancerM A Bookman, J S Berek
Cancer Treatment and Research|January 1, 1994
Fine-needle aspiration cytology in the management of gynecologic oncology patientsL J Layfield, J S Berek
Seminars in Surgical Oncology|July 7, 2000
Ovarian cancer: epidemiology, biology, and prognostic factorsC H Holschneider, J S Berek
Obstetrics and Gynecology Clinics of North America|March 1, 1994
Laparoscopic management of the adnexal massW H Parker, J S Berek
Current Opinion in Oncology|October 1, 1989
Screening, diagnosis, and monitoring of gynecologic malignanciesF J Montz, J S Berek
Obstetrics and Gynecology|October 1, 1979
Massive exudative ascites produced from a tubal pseudocyst in chronic pelvic inflammatory diseaseJ S Berek, P D Darney
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Surgery during chemotherapy and at relapse of ovarian cancerJ S Berek, C Tropé, I Vergote
Gynecologic Oncology|March 1, 1993
Solitary recurrent metastasis of epithelial ovarian cancer in the spleenR Farias-Eisner, P Braly, J S Berek
Gynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B Bonavida
Obstetrics and Gynecology|February 1, 1988
Controversies in the management of cervical adenocarcinomaE Brand, J S Berek, N F Hacker
Pageof 18

Showing results (31-40 of 172) with videos related to

Sort By:
Pageof 18
Hematology/Oncology Clinics of North America|August 1, 1992
Biologic and immunologic therapy of ovarian cancerM A Bookman, J S Berek
Cancer Treatment and Research|January 1, 1994
Fine-needle aspiration cytology in the management of gynecologic oncology patientsL J Layfield, J S Berek
Seminars in Surgical Oncology|July 7, 2000
Ovarian cancer: epidemiology, biology, and prognostic factorsC H Holschneider, J S Berek
Obstetrics and Gynecology Clinics of North America|March 1, 1994
Laparoscopic management of the adnexal massW H Parker, J S Berek
Current Opinion in Oncology|October 1, 1989
Screening, diagnosis, and monitoring of gynecologic malignanciesF J Montz, J S Berek
Obstetrics and Gynecology|October 1, 1979
Massive exudative ascites produced from a tubal pseudocyst in chronic pelvic inflammatory diseaseJ S Berek, P D Darney
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Surgery during chemotherapy and at relapse of ovarian cancerJ S Berek, C Tropé, I Vergote
Gynecologic Oncology|March 1, 1993
Solitary recurrent metastasis of epithelial ovarian cancer in the spleenR Farias-Eisner, P Braly, J S Berek
Gynecologic Oncology|February 1, 1993
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotypeJ T Safrit, J S Berek, B Bonavida
Obstetrics and Gynecology|February 1, 1988
Controversies in the management of cervical adenocarcinomaE Brand, J S Berek, N F Hacker
Pageof 18